EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma

Vlad-Ionuţ Nechita iD, Nadim Al-Hajjar, Daniel-Corneliu Leucuța iD, Emil Moiş iD, Alin Fetti iD, Mihaela-Ancuţa Nechita, Florin Graur iD

Diagnostics · 30.05.2023 · 13 (11) · 1910

DOI: 10.3390/diagnostics13111910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 30.05.2023. Verfasst von Vlad-Ionuţ Nechita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street, No. 6, 400349 Cluj-…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of the study was to assess the relationship between inflammatory biomarkers (NLR—neutrophil-to-lymphocyte ratio, PLR—platelet-to-lymphocyte ratio, LMR—lymphocyte-to-monocyte ratio, SII—systemic immune-inflammation index) and overall survival in gastric cancer patients.

Methods

Over a six-year period (2016–2021), we conducted a longitudinal retrospective cohort research on 549 patients with resectable stomach adenocarcinoma. The overall survival was determined using the univariate and multivariate COX proportional hazards models.

Results

The age of the cohort varied between 30 and 89 years old, with an average age of 64.85 ± 10.51 years. Four hundred seventy-six patients (86.7%) had R0 resection margins. Eighty-nine (16.21%) subjects received neoadjuvant chemotherapy. Two hundred sixty-two (47.72%) patients died during the follow-up period. The median survival time in the cohort was 390 days. A significantly lower (p = 0.029—Logrank test) median survival was observed for R1 resections (355 days) in comparison with R0 resections (395 days). Significant differences in survival were observed regarding tumor differentiation, tumoral (T), and node (N) stage. No differences in survival were observed between the low or high value of inflammatory biomarkers (dichotomized by median value in the sample). In the COX univariate and multivariate regression models, elevated NLR proved an independent prognostic factor for lower overall survival [HR = 1.068, (95% CI 1.011–1.12)]. In this study, the other inflammatory ratios (PLR, LMR, and SII) did not prove as prognostic factors for gastric adenocarcinoma.

Conclusions

In resectable gastric adenocarcinoma, elevated NLR before surgery was associated with lower overall survival. PLR, LMR, and SII had no prognostic value for the patient’s survival.

Schlagwörter

Stichwörter der Autor:innen

gastric adenocarcinomainflammatory ratiossurgical resectionsurvival

Autor:innen und Institutionen

  • Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street, No. 6, 400349 Cluj-Napoca, Romania.
  • Octavian Fodor Regional Institute of Gastroenterology and Hepatology Cluj-Napoca, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
  • 3rd Department of Surgery, "Iuliu Hațieganu" University of Medicine and Pharmacy, Croitorilor Street, No. 19-21, 400162 Cluj-Napoca, Romania.
  • Ion Chiricuță Oncology Institute, Republicii Street, No. 34-36, 400015 Cluj-Napoca, Romania.

ORCID-Profile: Vlad-Ionuţ Nechita, Daniel-Corneliu Leucuța, Emil Moiş, Alin Fetti, Florin Graur

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy
  • “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania, Doctoral Research Program

Zitieren

APA

Nechita, V. I., Al-Hajjar, N., Leucuța, D. C., Moiş, E., Fetti, A., Nechita, M. A., & Graur, F. (2023). Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma. Diagnostics, 13(11), 1910. https://doi.org/10.3390/diagnostics13111910

Vancouver

Nechita VI, Al-Hajjar N, Leucuța DC, Moiş E, Fetti A, Nechita MA, et al. Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma. Diagnostics. 2023;13(11):1910. doi:10.3390/diagnostics13111910

BibTeX
@article{Nechita2023,
  author = {Nechita, Vlad-Ionuţ and Al-Hajjar, Nadim and Leucuța, Daniel-Corneliu and Moiş, Emil and Fetti, Alin and Nechita, Mihaela-Ancuţa and Graur, Florin},
  title = {Inflammatory Ratios as Survival Prognostic Factors in Resectable Gastric Adenocarcinoma},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {11},
  pages = {1910},
  doi = {10.3390/diagnostics13111910}
}
Kostenlos starten →